
Loading, please wait...

Loading, please wait...

Reliable infant ABO blood typing is a cornerstone of safe pediatric transfusion medicine. However, determining blood groups in neonates and young infants presents unique challenges. This difficulty primarily arises from the immature expression of A and B antigens on red cells and the delayed development of ABO antibodies. Recent clinical research has focused on streamlining laboratory workflows to ensure both speed and accuracy in these vulnerable populations.
Accurate blood grouping in infants is often complicated by physiological factors. Neonates generally possess only about one-third of the A and B antigen sites compared to adults. Furthermore, infants under four months of age do not typically produce their own ABO antibodies, and any detected antibodies are usually of maternal origin. Consequently, laboratories often rely solely on forward typing for very young infants. As the child grows, the transition to dual testing—both forward and reverse typing—becomes necessary to ensure a conclusive result.
Modern laboratories increasingly utilize automated systems like the ORTHO VISION analyser to manage high sample volumes. A recent comparative study evaluated this analyser against the traditional manual tube method. The results indicated an almost perfect agreement between the two methods, reflected in a weighted kappa score of 0.94. While the automated system is highly efficient, the study found that the manual method achieved a slightly higher conclusive rate in infants under four months (100% vs. 98.7%). This difference is often due to the manual method\'s superior sensitivity in detecting very weak antigen expressions that automation might occasionally miss.
Establishing a targeted manual reflex protocol is essential for optimizing infant ABO blood typing workflows. By using automated analysers as the primary screening tool and reserving manual tube testing for indeterminate cases, laboratories can significantly reduce turnaround times. In infants aged four months to one year, the automated system showed excellent performance in both forward and reverse typing. For this older group, discrepancies between forward and reverse grouping often require manual verification to resolve. This hybrid approach ensures that clinical decisions regarding transfusions are based on the most accurate data available.
The integration of automated technology with manual expertise creates a robust safety net. Automation provides the benefit of standardization and reduced human error in data entry. Meanwhile, the manual reflex protocol serves as a critical secondary check for samples with weak reactivity. By following a structured workflow, healthcare providers can ensure that even the most challenging infant samples are typed correctly, thereby minimizing the risk of transfusion-related complications in the pediatric intensive care unit and neonatal wards.
Infants have a lower density of A and B antigens on their red blood cells. Additionally, they do not produce their own ABO antibodies until they are several months old, making the standard reverse grouping unreliable in neonates.
Guidelines generally recommend starting both forward and reverse typing once an infant reaches four months of age. Before this age, forward typing is the standard practice due to the presence of maternal antibodies in the infant\'s circulation.
A manual reflex protocol ensures that any sample yielding an inconclusive result on an automated analyser is immediately re-tested using the manual tube method. This step captures weak reactions that automation might miss, ensuring 100% accuracy in blood group determination.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Ji E et al. Optimising the workflow for infant ABO blood typing: The role of automated analyser and a manual reflex protocol. Transfus Med. 2026 Apr 28. doi: 10.1111/tme.70081. PMID: 42050373.
Staves J et al. Good practice guidance document for managing indeterminate ABO blood groups to support safe decision-making. SHOT UK. 2024.
StatPearls Publishing. ABO Blood Group System. [Updated 2025 Apr 26].
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Optimising infant ABO blood typing through automated analysers and manual reflex protocols ensures high accuracy and efficient workflow for pediatric care....
4 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today